Literature DB >> 17981641

IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells.

Laurence A Turka1, Patrick T Walsh.   

Abstract

Although originally described as a potent T cell growth factor in vitro, the main non redundant role of interleukin-2 (IL-2) in vivo is now known to be the maintenance of peripheral T cell tolerance. As well as promoting the proliferation and survival of recently activated effector T cells, IL-2 also plays a critical role in regulatory T cell (Treg) homeostasis and has been variously described as promoting the thymic development, peripheral homeostasis and suppressive function of Tregs. These observations, stemming largely from studies on various murine models of IL-2 and IL-2 receptor deficiency, have prompted a greater understanding of the pro-tolerogenic nature of IL-2 dependent signaling. Here we discuss current knowledge concerning the importance of IL-2 mediated signaling in Treg biology as well as its relevance to possible therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981641     DOI: 10.2741/2773

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  43 in total

1.  Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.

Authors:  Elaine V Lourenço; Claudio Procaccini; Francesca Ferrera; Noriko Iikuni; Ram P Singh; Gilberto Filaci; Giuseppe Matarese; Fu-Dong Shi; Ernest Brahn; Bevra H Hahn; Antonio La Cava
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

2.  Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Ho-Jin Shin; Jeanette Baker; Dennis B Leveson-Gower; Aaron T Smith; Emanuela I Sega; Robert S Negrin
Journal:  Blood       Date:  2011-07-06       Impact factor: 22.113

3.  Loss of cholinergic phenotype in septohippocampal projection neurons: relation to brain versus peripheral IL-2 deficiency.

Authors:  Danielle M Meola; Zhi Huang; Michael King; John M Petitto
Journal:  Neurosci Lett       Date:  2013-02-13       Impact factor: 3.046

4.  Age-dependent divergent effects of OX40L treatment on the development of diabetes in NOD mice.

Authors:  Christine S Haddad; Palash Bhattacharya; Khaled Alharshawi; Alejandra Marinelarena; Prabhakaran Kumar; Osama El-Sayed; Hatem A Elshabrawy; Alan L Epstein; Bellur S Prabhakar
Journal:  Autoimmunity       Date:  2016-05-31       Impact factor: 2.815

5.  Activation of the arylhydrocarbon receptor causes immunosuppression primarily by modulating dendritic cells.

Authors:  Anika Bruhs; Thomas Haarmann-Stemmann; Katrin Frauenstein; Jean Krutmann; Thomas Schwarz; Agatha Schwarz
Journal:  J Invest Dermatol       Date:  2014-09-24       Impact factor: 8.551

Review 6.  MicroRNA networks in regulatory T cells.

Authors:  Xuehua Tang; Ruijing Tang; Yujun Xu; Qingling Wang; Yayi Hou; Sunan Shen; Tingting Wang
Journal:  J Physiol Biochem       Date:  2014-08-10       Impact factor: 4.158

Review 7.  Synthesizing biomolecule-based Boolean logic gates.

Authors:  Takafumi Miyamoto; Shiva Razavi; Robert DeRose; Takanari Inoue
Journal:  ACS Synth Biol       Date:  2013-02-15       Impact factor: 5.110

8.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

9.  The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice.

Authors:  Luiz Roberto Sardinha; Tainá Mosca; Rosa Maria Elias; Rogério Silva do Nascimento; Lígia A Gonçalves; Daniella Zanetti Bucci; Cláudio Romero Farias Marinho; Carlos Penha-Gonçalves; Maria Regina D'Império Lima; José Maria Alvarez
Journal:  PLoS Negl Trop Dis       Date:  2010-01-05

10.  Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.

Authors:  G Alì; L Boldrini; M Lucchi; A Picchi; M Dell'Omodarme; M C Prati; A Mussi; V Corsi; G Fontanini
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.